Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "ctDNA Reduction and Clinical Efficacy of the Darovasertib + Crizotinib Combination in Metastatic Uveal Melanoma"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Meredith McKean
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Meredith McKean
64 views
November 1, 2023
Comments 0
Login to view comments.
Click here to Login
Skin